Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Experimental Eye Research
|
April 30, 2021
Optimization of goblet cell density quantification methods
Mike Yang, William Ngo, Sruthi Srinivasan, et al.
The Laryngoscope
|
October 17, 2025
Nebulized Lidocaine Through a Channeled Endoscope for Office Laryngology Procedures
Dylan Z Erwin, Abigail N Kennedy, Matthew Y Liu, et al.
Critical Care Medicine
|
July 27, 2010
Premarin improves outcomes of spinal cord injury in male rats through stimulating both angiogenesis and neurogenesis
Sheng-Hsien Chen, Chao-Hung Yeh, Mike Yang-Sheng Lin, et al.
Frontiers in Veterinary Science
|
January 31, 2024
Prevention and long-term outcomes of naturally occurring canine heartworm infection in primary care settings
Kennedy Mwacalimba, Jo Ann Morrison, Patrick Ly, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 6, 2022
Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery
Marcus L Turner, Abu M Taha, Sean Yonamine, et al.
CMAJ Open
|
April 18, 2023
A retrospective population-based analysis of wait times for cataract surgery in Ontario, Canada
Marko M Popovic, Mack Hurst, Lori M Diemert, et al.
Gastroenterology
|
February 18, 2014
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice
Xin Li, Payton D Stevens, Jianyu Liu, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
August 28, 2025
Association of Rural or Urban Status, Region, and Institution Type with Cataract Surgery Wait Times in Ontario, Canada: A Retrospective, Population-Based Analysis
Huixin Anna Zhang, Marko M Popovic, Nishaant Bhambra, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2023
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy
Andrew C Johns, Mike Yang, Lai Wei, et al.
The Oncologist
|
April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer
Andrew C Johns, Mike Yang, Lai Wei, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Experimental Eye Research
|
April 30, 2021
Optimization of goblet cell density quantification methods
Mike Yang, William Ngo, Sruthi Srinivasan, et al.
The Laryngoscope
|
October 17, 2025
Nebulized Lidocaine Through a Channeled Endoscope for Office Laryngology Procedures
Dylan Z Erwin, Abigail N Kennedy, Matthew Y Liu, et al.
Critical Care Medicine
|
July 27, 2010
Premarin improves outcomes of spinal cord injury in male rats through stimulating both angiogenesis and neurogenesis
Sheng-Hsien Chen, Chao-Hung Yeh, Mike Yang-Sheng Lin, et al.
Frontiers in Veterinary Science
|
January 31, 2024
Prevention and long-term outcomes of naturally occurring canine heartworm infection in primary care settings
Kennedy Mwacalimba, Jo Ann Morrison, Patrick Ly, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 6, 2022
Clinical and Visual Field Outcomes Following Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery
Marcus L Turner, Abu M Taha, Sean Yonamine, et al.
CMAJ Open
|
April 18, 2023
A retrospective population-based analysis of wait times for cataract surgery in Ontario, Canada
Marko M Popovic, Mack Hurst, Lori M Diemert, et al.
Gastroenterology
|
February 18, 2014
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice
Xin Li, Payton D Stevens, Jianyu Liu, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
August 28, 2025
Association of Rural or Urban Status, Region, and Institution Type with Cataract Surgery Wait Times in Ontario, Canada: A Retrospective, Population-Based Analysis
Huixin Anna Zhang, Marko M Popovic, Nishaant Bhambra, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2023
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy
Andrew C Johns, Mike Yang, Lai Wei, et al.
The Oncologist
|
April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer
Andrew C Johns, Mike Yang, Lai Wei, et al.
Page
of 3